197 related articles for article (PubMed ID: 20133819)
1. Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis.
Heishi T; Hosaka T; Suzuki Y; Miyashita H; Oike Y; Takahashi T; Nakamura T; Arioka S; Mitsuda Y; Takakura T; Hojo K; Matsumoto M; Yamauchi C; Ohta H; Sonoda H; Sato Y
Am J Pathol; 2010 Apr; 176(4):1950-8. PubMed ID: 20133819
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
[TBL] [Abstract][Full Text] [Related]
3. [Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer].
Jia YT; Li ZX; Liu M; Chen SA; Zhang L; Wang YD
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):254-7. PubMed ID: 19615276
[TBL] [Abstract][Full Text] [Related]
4. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
[TBL] [Abstract][Full Text] [Related]
5. The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.
Shibata MA; Ambati J; Shibata E; Albuquerque RJ; Morimoto J; Ito Y; Otsuki Y
BMC Med; 2010 Nov; 8():69. PubMed ID: 21047425
[TBL] [Abstract][Full Text] [Related]
6. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
[TBL] [Abstract][Full Text] [Related]
7. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
[TBL] [Abstract][Full Text] [Related]
8. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
Hwang-Bo J; Bae MG; Park JH; Chung IS
BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
[TBL] [Abstract][Full Text] [Related]
9. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
[TBL] [Abstract][Full Text] [Related]
11. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
13. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
Skobe M; Hawighorst T; Jackson DG; Prevo R; Janes L; Velasco P; Riccardi L; Alitalo K; Claffey K; Detmar M
Nat Med; 2001 Feb; 7(2):192-8. PubMed ID: 11175850
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lymphatic metastases by a survivin dominant-negative mutant.
Xu GC; Zhang P; Leng F; Pan L; Li ZY; Yu DD; Shan Y; Yuan QZ; Wen Y; Mu B; Shi HS; Chen X; Wang CT
Oncol Res; 2012; 20(12):579-87. PubMed ID: 24139416
[TBL] [Abstract][Full Text] [Related]
15. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
[TBL] [Abstract][Full Text] [Related]
16. Development of a mouse model for lymph node metastasis with endometrial cancer.
Takahashi K; Saga Y; Mizukami H; Takei Y; Urabe M; Kume A; Suzuki M; Ozawa K
Cancer Sci; 2011 Dec; 102(12):2272-7. PubMed ID: 21910784
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508
[TBL] [Abstract][Full Text] [Related]
19. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis and tumor metastasis.
Pepper MS; Tille JC; Nisato R; Skobe M
Cell Tissue Res; 2003 Oct; 314(1):167-77. PubMed ID: 12883995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
